Vision-related quality of life: 12-month aflibercept treatment in patients with treatment-resistant neovascular age-related macular degeneration

被引：0
|
作者：
Meidong Zhu
Wijeyanthy Wijeyakumar
Adil R. Syed
Nichole Joachim
Thomas Hong
Geoffrey K. Broadhead
Haitao Li
Kehui Luo
Andrew Chang
机构：
[1] Sydney Retina Clinic & Day Surgery,Save Sight Institute
[2] Sydney Institute of Vision Science,Department of Statistics, Faculty of Science and Engineering
[3] The University of Sydney,undefined
[4] Macquarie University,undefined
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2017年 / 255卷
关键词：
Vision-related quality of life (VR-QoL); Neovascular age-related macular degeneration (nAMD); Intravitreal aflibercept; Anti-vascular endothelial growth factor (anti-VEGF); Treatment resistant; Prospective clinical trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：475 / 484
页数：9
相关论文
共 50 条
  • [1] Vision-related quality of life: 12-month aflibercept treatment in patients with treatment-resistant neovascular age-related macular degeneration
    Zhu, Meidong
    Wijeyakumar, Wijeyanthy
    Syed, Adil R.
    Joachim, Nichole
    Hong, Thomas
    Broadhead, Geoffrey K.
    Li, Haitao
    Luo, Kehui
    Chang, Andrew
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2017, 255 (03) : 475 - 484
  • [2] Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration: 12-Month Safety and Efficacy Outcomes
    Chang, Andrew A.
    Broadhead, Geoffrey K.
    Hong, Thomas
    Joachim, Nichole
    Syed, Adil
    Schlub, Timothy E.
    Toth, Levente
    Peto, Tunde
    Zhu, Meidong
    OPHTHALMIC RESEARCH, 2016, 55 (02) : 84 - 90
  • [3] Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-related Macular Degeneration
    Chang, Andrew A.
    Li, Haitao
    Broadhead, Geoffrey K.
    Hong, Thomas
    Schlub, Timothy E.
    Wijeyakumar, Wijeyanthy
    Zhu, Meidong
    OPHTHALMOLOGY, 2014, 121 (01) : 188 - 192
  • [4] INTRAVITREAL AFLIBERCEPT FOR TREATMENT-RESISTANT NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Chang, Andrew A.
    Li, Haitao
    Broadhead, Geoffrey K.
    Hong, Thomas
    Schlub, Timothy E.
    Wijeyakumar, Wijeyanthy
    Zhu, Meidong
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 41 : 52 - 52
  • [5] The effect of ranibizumab treatment on patients' vision-related quality of life in neovascular age-related macular degeneration
    Hoffmann, A.
    Hirneiss, C.
    Wolf, A.
    Finger, R. P.
    Kampik, A.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 : 148 - 149
  • [6] The impact of vision impairment on vision-related quality of life of patients with neovascular age-related macular degeneration
    Marakis, Theodoros P.
    Koutsandrea, Chrysanthi
    Poulou, Maria S.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2022, 32 (01) : 481 - 490
  • [7] RETINAL VASCULAR CHANGES IN TREATMENT-RESISTANT NEOVASCULAR AGE-RELATED MACULAR DEGENERATION PATIENTS TREATED WITH AFLIBERCEPT
    Wijeyakumar, Wijeyanthy
    Zhu, Meidong
    Hong, Thomas
    Broadhead, Geoffrey K.
    Chang, Andrew A.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2015, 43 : 113 - 114
  • [8] AFLIBERCEPT FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Verner-Cole, E. A.
    Davis, S. J.
    Lauer, A. K.
    DRUGS OF TODAY, 2012, 48 (05) : 317 - 329
  • [9] The Effect of Ranibizumab Treatment on Patients' Preferences and Vision-Related Quality of Life in Neovascular Age Related Macular Degeneration
    Hirneiss, C. W.
    Wolf, A.
    Finger, R. P.
    Kampik, A.
    Hoffmann, A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [10] Visual and Anatomical Outcomes of Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration
    Gharbiya, Magda
    Iannetti, Ludovico
    Parisi, Francesco
    De Vico, Umberto
    Mungo, Maria Laura
    Marenco, Marco
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
12345